SCHEMBL7964576

SCHEMBL7964576

C=CCn1c(=O)cc(Cl)[nH]c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.53
CYP3A4 P08684 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
ADORA3 P0DMS8 1/20 0.42
ADORA2B P29275 1/20 0.42
MEN1 O00255 3/20 0.38
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TDP1 Q9NUW8 2/20 0.36
ALDH1A1 P00352 2/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 1/20 0.35
RECQL P46063 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL126983 0.79 KMT2A (0.44) KMT2ACYP3A4CYP1A2CYP2D6ADORA3
SCHEMBL5440251 0.79 CYP3A4 (0.42) KMT2ACYP3A4CYP1A2CYP2D6ADORA3
SCHEMBL220200 0.76 KMT2A (0.57) KMT2ACYP3A4CYP1A2CYP2D6MEN1
SCHEMBL9289331 0.75 CYP3A4 (0.44) KMT2ACYP3A4CYP1A2CYP2D6ADORA3
SCHEMBL26948701 0.75 ALOX15 (0.40) KMT2ACYP3A4ADORA3ADORA2BMEN1
SCHEMBL9756675 0.75 ALDH1A1 (0.49) KMT2ACYP3A4CYP1A2CYP2D6ADORA3
SCHEMBL9414250 0.73 GAA (0.39) KMT2ACYP3A4CYP1A2CYP2D6ADORA3
SCHEMBL319866 0.73 KMT2A (0.73) KMT2ACYP3A4MEN1SMN1; SMN2ALDH1A1
SCHEMBL3297433 0.73 KMT2A (0.54) KMT2ACYP3A4CYP1A2CYP2D6ADORA3
SCHEMBL7152971 0.72 MEN1 (0.43) KMT2ACYP1A2MEN1TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399423-A1 POLYMERIC DISINFECTANTS AND USES THEREOF TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2023-12-14 US disclosed
US-20230399423-A1 POLYMERIC DISINFECTANTS AND USES THEREOF TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2023-12-14 US disclosed
WO-2001029010-A1 GRAM-POSITIVE SELECTIVE ANTIBACTERIAL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT MERCK & CO., INC. (US) 2001-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399423-A1 POLYMERIC DISINFECTANTS AND USES THEREOF CUTA, PRKDC, PIK3C3 KMT2A 388/4885CYP3A4 1547/4885CYP1A2 1045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.